Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
dietary supplement
|
| gptkbp:abbreviation |
gptkb:FDA
|
| gptkbp:compatibleWith |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:derivedFrom |
Fadogia agrestis plant
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA (as dietary supplement)
|
| gptkbp:isNotApprovedBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:legalStatus |
unregulated in many countries
|
| gptkbp:marketedAs |
dietary supplement
|
| gptkbp:mayHaveSideEffects |
gastrointestinal discomfort
liver toxicity (potential) |
| gptkbp:mayReferTo |
Fadogia agrestis
|
| gptkbp:popularFor |
bodybuilding community
|
| gptkbp:sells |
powder form
capsule form |
| gptkbp:usedFor |
testosterone support
|
| gptkbp:bfsParent |
gptkb:Turmeric_extract
gptkb:HMB gptkb:Evening_primrose_oil |
| gptkbp:bfsLayer |
7
|